Atlas Trials

Study of MIBG-I131 in Patients With Well Differentiated Neuroendocrine Tumors

Clinical trial NCT04831567 · WITHDRAWN

Trial details

NCT number
NCT04831567
Sponsor
AC Camargo Cancer Center
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2021-02-04
Primary completion
2022-05-13
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.